ImaginAb

ImaginAb

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imagingby re-engineering antibodies into small proteins.
Type
B2c
Raised
$46.8M
Follow us
Alexa global traffic share